Viewing StudyNCT05689047

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 6:30 PM
Last Modification Date: 2024-10-26 @ 2:49 PM
Study NCT ID: NCT05689047
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-07-12
First Post: 2023-01-09
Brief Title: Phase IIa Proof of Concept Study of M5717-Pyronaridine in Adults and Adolescents With Acute Uncomplicated Plasmodium Falciparum Malaria CAPTURE 1
Sponsor: Merck Healthcare KGaA Darmstadt Germany an affiliate of Merck KGaA Darmstadt Germany
Organization: Merck Healthcare KGaA Darmstadt Germany an affiliate of Merck KGaA Darmstadt Germany
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Acute Malaria
Keywords:
Name View
Plasmodium eukaryotic translation Elongation Factor 2 View
M5717 View
Plasmodium mutants View
Acute Malaria View
Pyronaridine View
Plasmodium falciparum View
Polymerase chain reaction View
Adequate Clinical and Parasitological Response View